A specialized medical technology solution provider helping medtech innovators navigate the faster, smarter era of modern healthcare. Delivering an integrated, end-to-end approach that unites strategy, analytics, and digital execution across the full product lifecycle — from early innovation through successful commercial launch. For more info: https://www.zs.com/industry-insights/medical-technology

U.S. health plans lose hundreds of billions annually to improper payments, fraud, and administrative waste. Health plan payment integrity teams struggle with manual error detection, reactive post-pay processes, vendor overload, and fragmented data integration. For more info: https://www.zs.com/insights/ai-tackles-payment-integrity-for-health-plans

Clinical trial optimization starts with understanding protocol complexity at scale. With 80% of global trials reporting enrollment-related delays, a data-driven approach to protocol design helps sponsors identify and address risk areas at procedural, visit, and study levels. Advanced analytics with proprietary benchmarking tools evaluate complexity across clinical, operational, and human-centric dimensions. For more info: https://www.zs.com/insights/zs-data-driven-clinical-trials-protocol-design-optimization

Generative AI is redefining ai patient engagement, enabling healthcare systems to deliver personalized, patient-first experiences across the full care continuum. Unlike predictive models, generative AI ingests unstructured data and produces human-like interactions with minimal prompting—guiding patients through prevention, diagnosis, and recovery. For more info: https://www.zs.com/insights/patient-first-health-generative-ai-reshaping-care-experience

Expert brand and messaging consulting that helps organizations genuinely understand their customers — including preferences, motivations, contexts, and decision-shaping barriers. Leveraging AI-enabled workflows, this practice designs messages and experiences that proactively remove friction before it's felt. For More info: https://www.zs.com/capabilities/marketing/brand-messaging-customer-insights

In today’s dynamic deal environment, successful mergers, acquisitions, and partnerships require specialized acquisition strategy consulting. Services cover target screening, commercial due diligence, integration planning, and synergy realization. Data analytics drive informed valuations and operational transformation. For more info: https://www.zs.com/capabilities/strategy-and-transformation/mergers-acquisitions-partnerships

Expert telecommunications consulting services help telecom and technology companies embrace AI-led business models and enterprise transformation. With deep capabilities in data, analytics, AI, and digital solutions, firms in this space accelerate customer experience innovation, optimize sales strategies, and drive long-term commercial growth. For more info: https://www.zs.com/industry-insights/technology-and-telecommunications

Gen AI pharma content strategies are moving from pilots to proven results. By combining generative and classical AI within an intelligent content ecosystem, life sciences companies achieve up to 40% better digital engagement, 50% faster content tagging, and 25% more variant lift. Compliance approvals accelerate by 33% through smarter similarity scoring. For more info: https://www.zs.com/insights/generative-ai-pharma-content-personalization

Adapting to dynamic U.S. pharma policy: Strategies to future-proof your supply chain Rising trade tariffs and new pricing mandates are forcing a complete rethink of bio pharma supply chain strategy. For more info: https://www.zs.com/insights/us-pharma-policy-strategies-to-future-proof-your-supply-chain

Generative AI is transforming ai patient engagement by guiding patients across their full health journeys — from early detection to ongoing care interactions. Unlike predictive models, generative AI processes unstructured data to deliver human-like, empathetic responses with minimal prompting. For more info: https://www.zs.com/insights/patient-first-health-generative-ai-reshaping-care-experience

Market Access Solutions for Pharma Pricing & Value Strategy

Razor-thin margins, global pricing debates and increasing competition in pharma mean a shorter runway to get your asset strategy, access plan and execution right. Our consultants bring deep expertise in market access solutions — combining valuation, pricing and value communication with advanced analytics and AI-powered tools. For more info: https://www.zs.com/solutions/value-and-access

Heading into 2026, the pharmaceutical and biotech industries face an operating environment in flux. Each year, we step back to assess how the healthcare landscape is shifting and how pharma is adjusting to compete within it. The pharmaceutical industry outlook for 2026 is defined by regulatory volatility, AI acceleration and breakthrough science. For more info: https://www.zs.com/insights/pharma-industry-outlook-2026